- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies
Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 13, 2023
Companies with a Value score of at least 3, ordered by Value score
27 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SOBISwedish Orphan Biovitrum | kr235.80 | -7.9% | 12.0% | kr69.9b | kr285.80 | PE22.1x | E21.1% | n/a | ||
| PFEPfizer | US$422.60 | -4.5% | -9.3% | US$228.0b | US$536.31 | PE7.2x | E-13.8% | 4.1% | ||
| CYXOCyxone | kr0.71 | 1.9% | 6.4% | kr70.2m | n/a | PS9x | E65.9% | n/a | ||
| ORXOrexo | kr10.60 | -1.9% | -44.2% | kr364.3m | kr35.83 | PB2.8x | E91.9% | n/a | ||
| BICOBICO Group | kr57.10 | -9.4% | -42.7% | kr4.0b | kr132.50 | PS1.6x | S14.3% | n/a | ||
| ALZAlzinova | kr3.02 | -13.1% | 15.1% | kr134.3m | kr10.00 | PS8.1x | E134.1% | n/a | ||
| GEANGenetic Analysis | kr1.52 | -5.9% | -60.6% | kr37.9m | kr3.50 | PS1.8x | E66.4% | n/a | ||
| CALTXCalliditas Therapeutics | kr129.60 | 1.2% | 85.5% | kr7.7b | kr259.80 | PS9.6x | E49.0% | n/a | ||
| SENZASenzaGen | kr12.40 | 8.3% | 31.9% | kr299.9m | kr18.25 | PS7.2x | E98.6% | n/a | ||
| SPAGOSpago Nanomedical | kr0.82 | 3.0% | -71.7% | kr74.6m | kr2.50 | PS12x | E86.1% | n/a | ||
| KLARKlaria Pharma Holding AB (publ.) | kr0.56 | -14.6% | -87.3% | kr59.6m | kr1.30 | PS4.9x | E69.2% | n/a | ||
| BIOA BBioArctic | kr304.20 | 6.8% | 309.1% | kr26.8b | kr399.20 | PE82x | E46.7% | 0% | ||
| MOBMoberg Pharma | kr2.39 | -4.2% | 3.0% | kr234.4m | kr6.80 | PS1132.2x | S96.8% | n/a | ||
| NEWBRYNewbury Pharmaceuticals | kr5.48 | -2.8% | -31.3% | kr107.0m | kr8.50 | PS15.3x | E7.0% | n/a | ||
| SPRINTSprint Bioscience | kr0.70 | 1.4% | -80.5% | kr48.9m | kr1.60 | PS588.6x | S48.2% | n/a | ||
| ATANAAttana | kr0.13 | -12.7% | -82.7% | kr35.7m | n/a | PS2.7x | E-14.5% | n/a | ||
| ENZY BTAEnzymatica | kr4.25 | -8.2% | n/a | kr607.8m | kr7.73 | PS12.7x | E86.7% | n/a | ||
| DVYSRDevyser Diagnostics | kr83.00 | -1.7% | 13.7% | kr1.3b | kr109.85 | PS9.9x | E92.0% | n/a | ||
| BONEXBonesupport Holding | kr108.60 | 7.5% | 180.2% | kr7.1b | kr154.00 | PS18.5x | E103.9% | n/a | ||
| ENZYEnzymatica | kr3.12 | 8.2% | -37.1% | kr511.7m | kr5.26 | PS8.8x | E77.2% | n/a | ||
| CANTA BTACantargia | kr5.01 | n/a | n/a | kr512.5m | kr37.22 | PB1.2x | E79.2% | n/a | ||
| ONCOZOncoZenge | kr7.20 | -27.9% | 160.4% | kr84.3m | kr3.90 | PB2.5x | E41.9% | n/a | ||
| BINVBioInvent International | kr27.60 | 0.4% | -34.4% | kr1.8b | kr79.00 | PS5.6x | E70.9% | n/a | ||
| PROBProbi | kr187.50 | 0.8% | -36.8% | kr2.1b | n/a | PE46.6x | E21.3% | 0.7% |